What Is Quetiapine-Induced Myopathy?

Quetiapine-induced myopathy refers to muscle-related side effects, including muscle pain, weakness, and, in severe cases, rhabdomyolysis, associated with the use of quetiapine, an atypical antipsychotic medication. These adverse effects can occur even at therapeutic doses and may lead to significant morbidity if not promptly recognized and managed.

How Does Quetiapine Cause Myopathy?

The exact mechanisms by which quetiapine induces myopathy are not fully understood. However, several potential pathways have been proposed:

• Direct Muscle Toxicity: Quetiapine may have a direct toxic effect on muscle cells, leading to muscle injury and inflammation.
• Neuroleptic Malignant Syndrome (NMS): Although rare, NMS is a life-threatening condition associated with antipsychotic medications, including quetiapine, characterized by muscle rigidity, fever, altered mental status, and autonomic dysfunction.
• Drug Interactions: Concurrent use of quetiapine with other medications that affect muscle function or metabolism may increase the risk of myopathy.

Symptoms of Quetiapine-Induced Myopathy?

Patients experiencing quetiapine-induced myopathy may present with:

• Muscle pain or tenderness
• Muscle weakness
• Elevated creatine kinase (CK) levels
• Tea-colored urine (suggestive of myoglobinuria)
• Fever and altered mental status (in cases of NMS)

Who Is at Risk for Developing This Condition?

Certain factors may increase the risk of developing quetiapine-induced myopathy:

• High Dosage: Higher doses of quetiapine may be associated with an increased risk of myopathy.
• Renal or Hepatic Impairment: Impaired kidney or liver function can lead to higher plasma levels of quetiapine, increasing the risk of side effects.
• Concurrent Use of Other Medications: Combining quetiapine with other drugs that affect muscle function or metabolism may potentiate the risk.
• Pre-existing Muscle Disorders: Individuals with underlying muscle conditions may be more susceptible to drug-induced myopathy.

How Is Quetiapine-Induced Myopathy Diagnosed?

Diagnosis involves:Thieme

• Medical History Review: Assessing recent quetiapine use and symptom onset.
• Physical Examination: Evaluating for signs of muscle weakness or tenderness.
• Laboratory Tests: Measuring serum creatine kinase (CK) levels to assess muscle injury.
• Urinalysis: Checking for myoglobinuria, which may indicate rhabdomyolysis.
• Electromyography (EMG): Assessing electrical activity in muscles to detect abnormalities.

What Are the Treatment Options?

Management of quetiapine-induced myopathy includes:

• Discontinuation of Quetiapine: Stopping quetiapine therapy is essential to prevent further muscle damage.
• Supportive Care: Providing intravenous fluids to maintain hydration and support kidney function.
• Monitoring: Regular monitoring of renal function and CK levels.
• Medications: Administering medications to manage symptoms and prevent complications, as needed.

What Is the Prognosis?

The prognosis depends on the severity of the myopathy and the promptness of treatment:

• Mild Cases: With early detection and appropriate management, recovery is often complete.
• Severe Cases: Delayed treatment may lead to complications such as acute kidney injury or permanent muscle damage.

How Can Quetiapine-Induced Myopathy Be Prevented?

Preventive measures include:

• Appropriate Dosing: Using the lowest effective dose of quetiapine.
• Regular Monitoring: Periodic assessment of muscle function and CK levels during quetiapine therapy.
• Patient Education: Informing patients about potential side effects and encouraging prompt reporting of symptoms.
• Avoiding Drug Interactions: Being cautious with concurrent use of other medications that affect muscle function or metabolism.